McKesson Corporation Stock News

Coca-Cola's revenue climbed despite last-year's tough economic environment. McKesson may be entering a new phase of growth as it focuses on biopharma services and oncology.

McKesson isn't about to explode in value anytime soon. But it'll likely continue to grow at a plodding pace for the next few decades.

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.

The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.

The demand for medical product distribution is set to grow and McKesson is the clear leader of the industry. Sanofi's stacked product portfolio and pipeline should power double-digit annual earnings g

McKesson has had 10 consecutive years of annual revenue increases. It has increased its dividend for 15 consecutive years, including double-digit boosts the past two years.

Stock market investors have been on a rollercoaster ride over the past year. The Federal Reserve continues to be hawkish in controlling inflation.

The banking crisis is costing most S&P 500 investors serious money. Even Warren Buffett is taking his lumps.

McKesson has divested most of its European businesses and is focusing on its highest-growth areas. The healthcare company's growth isn't impressive, and its COVID-19 tailwind is fading.

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

McKesson Corporation has a strong position in the industry, and with a strong last quarterly performance, the current share price seems to offer a good entry point. There are many tailwinds for the co

McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

McKesson's stock has significantly outperformed the S&P 500 over the past five years.

Hershey (HSY), ParkerHannifin (PH), The Interpublic Group (IPG), Microchip Technology (MCHP), and McKesson (MCK) could be solid choices for your portfolio amid rising yields.